** Abbott India ABOT.NS jumps 3.5% post Q4 results
** Drugmaker's profit rises 28% y/y in Q4; rev from ops up 11%
** Co's earnings boosted by strong demand for gastrointestinal and anti-infective drugs
** Stock is top gainer in nifty pharma index .NIPHARM, which is down 0.4%
** YTD shares up 2%, set to extend gains for a second straight session
** Broader market nifty 50 index .NSEI down 0.2% on Friday
(Reporting by Yagnoseni Das in Bengaluru)
((Yagnoseni.Das@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。